When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Heron Therapeutics (NASDAQ:HRTX) has resubmitted its NDA to the FDA for HTX-011, an investigational agent for the management of postoperative pain. The Company anticipates a 6-month review by the FDA.
More news on: Heron Therapeutics, Inc., Healthcare stocks news,